AstraZeneca Hails Trial Results For Covid Treatment
Fahad Shabbir (@FahadShabbir) Published August 20, 2021 | 02:44 PM
Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for Covid-19 symptoms
London, (UrduPoint / Pakistan Point News - 20th Aug, 2021 ) :Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for Covid-19 symptoms.
The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to the disease.
A new trial of 5,197 participants who had not been exposed showed a 77-percent reduced risk of developing symptomatic disease, with no severe cases recorded, Astra said in a statement.
A previous trial of the AZD7442 drug had shown it only reduced the risk of developing symptoms by 33 percent, which it concluded in June was not statistically significant.
The data show that one dose could "quickly and effectively prevent symptomatic Covid-19", said Myron Levin, principal trial investigator.
"With these exciting results, AZD7442 could be an important tool in our arsenal to help people who may need more than a vaccine to return to their normal lives.
" It is hoped that the drug could be used alongside vaccines for those who need more protection, affording up to 12 months of defence.
Participants in the trial were adults who were poor responders or intolerant to vaccines, or who had increased risk of infection because of their locations or circumstances.
The US government has funded the development of AZD7442 and has agreements to receive 700,000 doses.
The company will now send the data to health authorities for potential emergency use authorisation or conditional approval.
AstraZeneca already makes the most widely offered vaccine in the UK, although those under 40 are offered Pfizer or Moderna instead because of concerns over possible side effects.
Related Topics
Recent Stories
PCB dismisses FICA's claims of unpaid dues in PSL
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 28 March 2024
Today Gold Rate in Pakistan 28 March 2024
Niger says US to submit plan to 'disengage' troops
Venezuelan opposition registers unknown poll contender after obstacles
Van Aert breaks collarbone, ribs in Flanders fall
Russian attacks kill three as Ukraine calls for more air defence
Climate change is messing with how we measure time: study
Minister discusses bilateral issues with Turkiye Ambassador
Urdu poet Safiya Shamim remembered on birth anniversary
Turbat attack martyr laid to rest with full military honours
Police break up Togo opposition event: AFP journalists
More Stories From Health
-
Increased diagnostic testing for drug resistance
5 days ago -
IRD releases groundbreaking results of end TB programme
7 days ago -
Increased diagnostic testing for drug resistance TB will enhance patients’ treatment outcome
10 days ago -
JRF to provide insulin to underprivileged diabetic patients
12 days ago -
MBBS third professional annual exams 2023: check results here
13 days ago -
CM Maryam visits PIC, inquiries after patients
15 days ago
-
Health expert recommends exercise for weight loss in Ramazan
17 days ago -
Blood camp held at SNGPL office
17 days ago -
Free Medical camp for people with mental, physical disabilities
23 days ago -
Breast cancer has become most common disease in few years: expert
23 days ago -
Punjab Healthcare Commission shuts down 634 illegal treatment centers
23 days ago -
COMSTECH, Al-Shifa Trust team conduct free cataract eye surgeries in Somalia
23 days ago